Press Releases and Events
PRESS RELEASES
Press Release | April 13, 2022
Press Release | April 11, 2022
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
READ MORE
Press Release | March 30, 2022
Crinetics Reports Positive Top-Line Results from CRN04777 Phase 1 MAD Cohorts
READ MORE
Press Release | March 30, 2022
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
READ MORE
Press Release | March 21, 2022
Crinetics Pharmaceuticals Appoints Chris Robillard as Chief Business Officer
READ MORE
Press Release | March 14, 2022
Crinetics Pharmaceuticals Appoints Caren Deardorf to Board of Directors
READ MORE
Press Release | March 10, 2022
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
READ MORE
Press Release | March 1, 2022
Crinetics Pharmaceuticals Expands Executive Team with Appointment of James Hassard as Chief Commercial Officer
READ MORE
Press Release | February 28, 2022
Crinetics Pharmaceuticals and Sanwa Kagaku Kenkyusho Enter into Exclusive Licensing Agreement for the Development and Commercialization of Paltusotine in Japan
READ MORE
Press Release | February 9, 2022
Crinetics Pharmaceuticals to Participate in SVB Leerink Global Healthcare Conference
READ MORE
WEBCAST
PRESS RELEASETransforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine-rooted care.
Email Signup
You are now leaving Crinetics.com
Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.
